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Cytoprotective roles for autophagy
Kevin Moreau1, Shouqing Luo1 and David C RubinszteinMacroautophagy (referred to as autophagy in this review) is a
genetically regulated bulk degradation program conserved from
yeast to humans, in which cytoplasmic substrates, such as
damaged organelles and long-lived proteins, are delivered to
lysosomes for degradation. In this review, we consider recent
data that highlight possible mechanisms whereby autophagy
mediates cytoprotective effects. These include the ability of
autophagy tobuffer against starvation, protect against apoptotic
insults and clear mitochondria, aggregate-prone proteins and
pathogens. These effects are pertinent to the roles of autophagy
in normal human physiology, including the early neonatal period
and ageing, as well as a variety of diseases, including cancer,
neurodegenerative conditions and infectious diseases.
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Introduction
Autophagy involves the formation of double-layered
membrane structures around a portion of cytosol [1].
These membrane structures, called autophagosomes, are
trafficked to lysosomes in a dynein-dependent manner
along microtubules. The fusion of the outer membrane
of the autophagome and the lysosome leads to the for-
mation of autolysosome, where the contents are degraded.
The identification of autophagy genes (Atg genes) in
yeast heralded the start of a newera for autophagy research,
as it allowed the identification of mammalian orthologues
of these genes and many studies that have elucidated
critical roles for this process in normal physiology and
disease [2].
Autophagy occurs at basal, constitutive levels and is
upregulated under physiological stress, for example,
Open access under CC BY license.Current Opinion in Cell Biology 2010, 22:206–211nutrient deprivation and growth factor withdrawal.
Autophagy is essential in maintaining homeostasis, which
requires protein degradation for energy needs, by remov-
ing damaged substrates for recycling. As a result, autop-
hagy is important in promoting cell survival in different
conditions, such as protein aggregate-induced stress,
nutrient and growth factor deprivation, ER stress and
pathogen infection [3]. The demand on autophagy differs
among different cell types. It plays particularly important
roles in non-dividing cells, for example, neurons and
myocytes [3].
Cytoprotective effects of autophagy
The occurrence of increased autophagosomes in dying/
dead cells in certain contexts led to the idea that autop-
hagymay be a primary deathmediator. This phenomenon
was termed type-II cell death, to differentiate it from
apoptotic (or type-I cell death) [4]. Since increased num-
bers of autophagosomes can result both from increased
autophagosome synthesis, as well as from decreased
autophagosome–lysosome fusion, cells showing type-II
cell death may not always have increased autophagic flux.
Although there is mounting evidence that this may be a
relevant pathway in Drosophila metamorphosis [5], the
role of autophagy as a positive mediator of cell death is
unclear and not well understood in mammalian systems.
On the other hand, many studies suggest that impaired
autophagy sensitises cells and organisms to toxic insults
[6,7].
One of the first studies that addressed this question in
mammalian cells [8] reported that cells exhibit type-II
cell death morphology when lysosome–autophagosome
fusion is inhibited, suggesting that autophagy may be
cytoprotective. The lysosomotropic agent hydroxychlor-
oquine (HCQ) leads to the accumulation of autophagic
vacuoles (AV) that triggers a pre-lethal program, which
can be suppressed by mitochondrial membrane per-
meability inhibitors, or caspase antagonists. AV accumu-
lation precedes DCm loss, which marks imminent cell
death and apoptosis. Consistent with these data, Raviku-
mar et al. [9] showed that genetic or chemical inhibition of
autophagy sensitised cells to pro-apoptotic insults and
that autophagy induction with rapamycin or Beclin 1
overexpression protected cells and Drosophila from pro-
apoptotic agents. These data suggested that the ability of
autophagy to reduce the mitochondrial load in cells and
thereby lower the amount of pro-apoptotic molecules
(like cytochrome c) released from mitochondria after
apoptotic insults, was an important contributor to the
protective effects of autophagy.www.sciencedirect.com
Cytoprotective roles for autophagy Moreau, Luo and Rubinsztein 207Autophagy alleviates starvation-induced
stress
One of the archetypal roles of autophagy is to enable cell
survival during starvation conditions. In unicellular organ-
isms such as yeast and protozoans, cells with knockouts of
autophagy genes die shortly after starvation induction,
while they are viable in normal nutrient conditions [7].
This scenario has parallels in mammalian cells. IL-3 is
essential for survival and growth of bone marrow cells and
IL-3 deprivation induces cell death in these cells. IL-3
withdrawal results in progressive atrophy of Bax/Bak/
(apoptosis-incompetent) cells generated from bone mar-
row and increases autophagy, and these IL-3-dependent
Bax/Bak/ cells undergo autophagy to maintain cell
survival for over 20 weeks, while the inhibition of autop-
hagy leads to cell death. The addition of IL-3 re-activates
the catabolic process that maintains cell survival [10].
Although cell death will occur inevitably in persistent
starvation conditions, this process can be greatly delayed
in autophagy-competent cells, which survive by stopping
growth and cell division. Conversely, autophagy inhi-
bition sensitises cells to nutrient starvation-induced cell
death [8].
Currently, it is widely accepted that autophagy is a self-
limited survival strategy, rather than a primary or irre-
versible death trigger. Indeed, autophagy induction may
also translate into a longevity mediator in a wide-range of
organisms ([11] and references therein).
Mechanisms of autophagy-mediated survival
The mechanisms whereby autophagy mediates its cyto-
protective effects are still the subject of active investi-
gation by a number of laboratories. It is likely that these
may vary according to the stress that the relevant cells and
organisms are exposed to, and the cell types involved. In
the rest of this review, we will consider these different
mechanisms.
Nutrient and bioenergetic homeostasis
By promoting catabolic reactions, autophagic degradation
of proteins, organelles, membranes and lipid droplets
[12] generates amino acids and fatty acids and other
new metabolic substrates, which provide building blocks
and maintain bioenergetics for protein synthesis and ATP
energy production. These events are particularly import-
ant for cells deprived of nutrients.
Autophagy is not only essential for cell survival but also
essential for organismal survival when nutrients are
scarce. An important period where this occurs in mam-
mals is in the early neonatal period, before breastfeeding
is established [13,14]. Mice lacking Atg5 or Atg7, which are
essential for autophagosome formation, die during this
neonatal stage. Indeed, if neonatal mice are prevented
from breastfeeding, the survival time of starved autop-
hagy-deficient neonates is much shorter than that of wild-www.sciencedirect.comtype counterparts. Conversely, the survival of the autop-
hagy-deficient mice can be extended if they are hand-fed.
These studies showed that autophagy was required for
the liberation of energy during this period of nutrient
deprivation.
Removal of misfolded and aggregate-prone
proteins
During aging, cells accumulate increasing amounts of
misfolded cytoplasmic proteins, which frequently form
various types of aggregates. This phenomenon is accen-
tuated in a range of neurodegenerative diseases, in-
cluding Alzheimer’s diseases, Parkinson’s diseases and
Huntington’s diseases. One of the roles of autophagy is to
limit the accumulation of aggregate-prone intracytoplas-
mic proteins [15]. If autophagy is blocked, such proteins
accumulate. Conversely, if autophagy is induced, the
clearance of such proteins is enhanced and their toxicities
are attenuated in cell, Drosophila, zebrafish and mouse
models [16–19,20].
When autophagy is compromised in normal mice, one also
sees the accumulation of inclusions that are ubiquitinated
[14,21,22,23]. Subsequent work showed that these
inclusions are also decorated with antibodies against a
ubiquitin-binding protein, called p62, that is an autop-
hagy substrate. Studies in mice and Drosophila [21,24]
showed that such inclusions did not form in p62-null
animals when autophagy was compromised. One of the
reasons that this occurs may be because p62 is a major
constituent of such inclusions, possibly because it can
oligomerise, and that it then serves as a seed for the
generation of the ubiquitinated inclusions by sequester-
ing ubiquitinated proteins onto its ubiquitin-binding
domain [25].
p62 regulation, proteasome inhibition and
tumourigenesis
If animals do not express p62, then the toxicity of
autophagy compromise is also suppressed [24]. One
way that this may be mediated is because p62 appears to
impact on the efficiency of the ubiquitin–proteasome
system. When autophagy is compromised, p62 accumu-
lates. This leads to a partial block in flux through the
ubiquitin–proteasome system, but does not inhibit pro-
teasome catalytic activity. P62 is both necessary and
sufficient for this effect and appears to act by sequester-
ing ubiquitinated substrates away from the normal
proteins that mediate their delivery to the proteasome
for degradation. When autophagy is inhibited, this leads
to the accumulation of proteasome substrates (that are
not autophagy substrates), like p53. The predicted effect
of the accumulation of such short-lived cellular regulators
is cell stress and increased susceptibility to toxic insults.
Thus, a secondary compromise in the ubiquitin–protea-
some system may underlie some of the toxic effects of
autophagy deficiency [25].Current Opinion in Cell Biology 2010, 22:206–211
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reported to play diverse roles in tumourigenesis [26,27].
Jin et al. showed that p62 acts as a hub that recruits a
ubiquitinated form of caspase 8 to p62 foci, allowing full
activation of this caspase [26]. Mathew et al. reported that
p62 accumulation in autophagy-incompetent cells leads
to increased production of reactive oxygen species, which
causes cellular perturbations like increased chromosomal
instability, deregulated signal transduction and gene
expression and increased predisposition to apoptosis in
some cells. However, in solid tumours characterized by
hypoxia, autophagy is upregulated, which promotes p62
degradation [28]. In this situation, downregulation of p62
increases Ras/ERK activity that enhances the survival and
proliferation of cancer cells. However, this may be more
complex, since p62 levels are often high in tumours,
suggesting that the rate of p62 accumulation exceeds
its degradation [29]. Indeed, p62 promotes lung adeno-
carcinoma formation by activated K-ras [29]. This, and
the data of Matthew et al. [27] suggest that p62 accumu-
lation may promote oncogenesis. These new findings
confirm the need for further investigation into the
relationship between autophagy, p62 and tumourigenesis
and tumour survival, since these may also be dependent
on the cell type, tumour, tumour stage and environmental
conditions.
Cancers and p53 regulation of autophagy
The principal tumour-suppressor protein, p53, transacti-
vates a number of genes with a variety of functions
including cell cycle arrest, apoptosis and metabolism.
p53 is inactivated in approximately half of human cancers,
either by mutations, or by increased expression of its
inhibitors, which enhances tumour survival and devel-Figure 1
p53 regulation of autophagy and cell death. In basal conditions, cytoplasmic p
increasing ROS (reactive oxygen species) production and by triggering MOM
tumour cell survival where p53 function is lost, either by mutation or by inhi
Enhancement of autophagy, including mitophagy, contributes to cell surviva
Current Opinion in Cell Biology 2010, 22:206–211opment. Recent findings have demonstrated a role of p53
in autophagy regulation. Depending on p53 localisation
(nuclear or cytoplasmic), autophagy is induced or inhib-
ited, which contributes to cell survival or cell death
responses. In basal conditions, Tasdemir et al. observed
that cytoplasmic p53 inhibits autophagy by mTOR acti-
vation via AMP-dependent kinase [30] (Figure 1). In
p53-deficient cells (either by p53 mutation, inhibition or
degradation), autophagy is restored and promotes cell
survival, possibly via mitophagy (mitochondrial autop-
hagy) [30] (Figure 1). The cytoprotective effect of
autophagy, while beneficial to cancer cells, is bad for
the patient. Another relationship between p53 and autop-
hagy was found by Bensaad et al., involving the phospha-
tase TIGAR, a p53-inducible protein [31,32]. TIGAR is
involved in restraining levels of reactive oxygen species
inside the cell, thereby inhibiting autophagy. When
TIGAR function is inhibited, the increased levels of
reactive oxygen species lead to autophagy induction [32].
Mitophagy
Mitochondria play an important role in cell homeostasis
and cell survival by regulating energy production (oxi-
dative phosphorylation) and apoptosis. Consequently,
cells need to be able to monitor mitochondrial quality
and quantity. The major route for mitochondrial degra-
dation is via mitophagy. However, the molecular mech-
anisms for mitochondria’s recognition by autophagy
(either selective, random or both) remain to be clarified
in mammalian systems. Recently, an important contri-
bution to our understanding of mitophagy in yeast has
been reported by the discovery of a mitophagy receptor,
Atg32 [33,34] (Figure 2). Importantly, Atg32 is
involved only in mitophagy and not in bulk autophagy53 inhibits autophagy via mTOR activation, and can induce apoptosis by
P (mitochondrial outer membrane permeabilization). In the context of
bition, mTOR is inhibited, thereby leading to autophagy induction.
l by inhibiting ROS and MOMP.
www.sciencedirect.com
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Figure 2
Cytoprotective effect of mitophagy. Direct interaction of the yeast Atg32
protein or indirect interaction of the mammalian Parkin protein with the
autophagic protein LC3 leads to the degradation of mitochondria inside
autophagosomes, in a process called mitophagy. Mitochondrial
degradation protects cell against apoptosis by preventing ROS (reactive
oxygen species) formation and MOMP (mitochondrial outer membrane
permeabilization).or the Cvt pathway [33,34]. These two studies
indicate that mitophagy is indeed a selective process.
However, additional work is required in order to under-
stand the physiological significance of mitophagy, since
no defect in mitochondrial activity has been found in
Atg32 knockout cells. Although an Atg32 homologue has
not been found in mammalian cells, mitophagy is
believed to be selective to some extent because it
employs the ubiquitin ligase, Parkin (mutated in rare
autosomal recessive forms of Parkinson’s disease), which
is translocated from the cytosol to dysfunctional mito-
chondria to promote selective degradation [35]. Parkin
may be acting though the ubiquitination of mitochondrialFigure 3
Cytoprotective effect of autophagy in the context of infectious diseases. In
mitophagy defects contribute to ROS (reactive oxygen species) production
bacteria can escape the vacuolar environment following vacuolar lysis, mem
dependent manner. Degradation of these membrane remnants, where specifi
preventing ROS formation.
www.sciencedirect.comproteins. Such ubiquitinated proteins may serve as bind-
ing sites for p62, which can then target the mitochondria
to autophagosomes via its interaction with LC3. In neu-
rodegenerative disorders, such as Parkinson’s disease
(PD), in which the accumulation of aggregated/misfolded
proteins and the dysfunction of mitochondria are the two
major defects, mitophagy appears to be cytoprotective
[36] (Figure 2). There may be other molecules that target
mitochondria for autophagic clearance in mammals, since
the expression of Parkin is limited. One candidate is Nix
(also known as Bnip3L), which is important for mito-
chondrial removal in erythroid maturation, and may also
play a role in mitophagy in other tissues [37].
Immune response
Autophagy has been demonstrated to play a role in the
clearance of pathogens like viruses and bacteria [38,39].
However, in some cases, autophagosomes serve as a
reservoir for pathogen replication [38,40]. In the study
of Alirezaei et al., simian immunodeficiency virus (SIV)-
infected microglia have impaired autophagy, resulting in
decreased neuronal survival [41]. Also, in HIV-infected
individuals, autophagy inhibition may contribute to neu-
rotoxicity [41] (Figure 3). Indeed, in the same study,
rapamycin treatment prevented neurodegenerative pro-
cesses by restoring autophagy [41]. Recent work has
implicated autophagy for membrane remnant clearance
following bacterial vacuolar exit into the cytosol [42].
The degradation of these membrane remnants by autop-
hagy is a p62-dependent process and contributes to
maintain homeostasis, as inflammatory response com-
ponents are specifically recruited on these structures
[42] (Figure 3).cases of viral infection that lead to autophagy inhibition (red arrows),
and thereby trigger cell death. In cases of bacterial infection, where
brane remnants are targeted by autophagy for degradation in a p62-
c inflammasome components are recruited, contributes to cell survival by
Current Opinion in Cell Biology 2010, 22:206–211
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Figure 4
Cytoprotective effect of autophagy. In stress conditions, autophagy exerts its prosurvival roles by promoting nutrient and bioenergetic homeostasis,
aggregate clearance, p62 regulation, mitophagy (for mitochondria-dependent apoptosis), and the removal of intracellular pathogens.Conclusion
In this review, we have covered some of the contexts
where autophagy may be cytoprotective (Figure 4). The
relationship between autophagy and cell death is complex
and this is, in part, influenced by the emerging data
showing coregulation of autophagy and apoptosis. For
example, Bcl-2 and Bcl-xl inhibit both apoptosis and
autophagy [43]. Also, the autophagy gene Atg5 has been
reported to induce apoptosis when overexpressed [44].
While autophagy generally protects against apoptosis,
recent data suggest that caspase activation during apop-
tosis inhibits autophagy because of cleavage and inacti-
vation of the autophagy protein Beclin-1 [45]. Thus, the
interplay between autophagy and apoptosis and other
forms of cell death is a field ripe for further exploration.
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